NCT00537459View on ClinicalTrials.gov

A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2006

Conditions
Premature Ejaculation
Interventions
DRUG

16448

Trial Locations (1)

BT9 6AD

GSK Investigational Site, Belfast

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY